Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Kalendarium

2017

Fredagen den 20 januari kl 09.00 disputerar Berne Eriksson.
Plats: Academicum, Medicinaregatan 3, sal: Arvid Carlsson
Titel: COPD: Incidence, prognosis and comorbidity with special focus on heart disease

2016

Fredagen den 10 juni kl 13.00 disputerar Taral Rameshchand Lunavat.
Plats: Academicum, Medicinaregatan 3, sal: Arvid Carlsson
Titel: Extracellular vesicles and RNA interference in tumors

Fredagen den 20 maj kl 13.00 disputerar Erik Rönmark.
Plats: Konferenscentrum Wallenberg, Medicinaregatan 20A
sal: Europa.
Titel: The association between eczema, asthma and rhinitis - population studies of prevalence and risk factors among adults

2015

Torsdagen den 21 maj kl 09.00 disputerar Stig Hagstad
Plats: Academicum, Medicinaregatan 3, sal: Arvid Carlsson.
Titel: COPD Among Never-Smokers. Prevalence, Risk Factors and Comorbidities, The Obstructive Lung Disease in Northern Sweden (OLIN) Studies Thesis XIII
 

2014

Torsdagen den 8 maj kl 09.30 har Taral R Lunavat halvtidsseminarium.
Plats: Academicum, Medicinaregatan 3, sal: Birgit Thilander
Titel: Melanoma releases distinct RNAs in subsets of extracellular vesicles.

Fredagen den 4 april kl. 13.00 disputerar Carina Malmhäll.
Plats: Konferenscentrum Wallenberg, Medicinaregatan 20A
sal: Lyktan.
Titel: T cell subsets in asthma and allergy - role of glucocorticoids, plasticity and microRNA-155

2013

Torsdagen den 13 juni kl. 09,00 disputerar Cecilia Lässer.
Plats: Academicum, Medicinaregatan 3, sal: Arvid Carlsson.
Titel: Exosomes - characterisation of the RNA and protein cargo

Tisdagen den 11 juni kl. 13.00 disputerar Jonas Eriksson.
Plats: Academicum, Medicinaregatan 3, sal: Arvid Carlsson.
Titel: Prevalence, risk factors and comorbidity of rhinitis, asthma and aspirin-intolerance in West Sweden

Fredagen den 8 februari kl. 13.00 disputerar Maria Eldh.
Plats: Academicum, Medicinaregatan 3, sal: Arvid Carlsson.
Titel: Exosomes and Exosomal RNA - A Way of Cell-to-Cell Communication.

2012

Fredagen den 23 november kl. 13.00 disputerar Linda Ekerljung.
Plats: Hörsal Ivan Östholm, LNC, Medicinaregatan 13
Titel: Asthma in West Sweden - a translational study from epidemiology to proteomics.

2011

Torsdagen den 15 december kl. 13.00 disputerar You Lu.
Plats: Academicum, Medicinaregatan 3, sal: Arvid Carlsson.
Titel: Eosinophils, their progenitors and T helper cells in allergic airway inflammation.

Tisdagen den 18 oktober kl. 10.00 har Jonas Eriksson halvtidsseminarium. Plats: Academicum, sal: Ingegerd Eriksson, Medicinaregatan 3.
Titel: Studier av prevalens, riskfaktorer och samvariation för astma, rinit och salicylidiosynkrasi.

Fredagen den 16 september kl. 13.00 disputerar Malin Axelsson.
Plats: Academicum, Medicinaregatan 3, sal: Arvid Carlsson.
Titel: Personality and adherence to medication treatment.

Torsdagen den 28 april kl. 13.00-16.00 AllergiCentrums vårmöte.

Torsdagen den 10 mars kl. 16.30 möte i styrgruppen för Krefting Research Centre.

Måndagen den 7 mars kl. 13.00 har Carina Malmhäll halvtidsseminarium. Plats: Academicum, sal: Ingegerd Eriksson, Medicinaregatan 3.
Titel: T-hjälpar celler vid inflammation i luftvägarna, balans och flexibilitet.

Måndagen den 28 februari kl. 10.00 har You Lu halvtidsseminarium. Plats: Academicum, sal: Ingegerd Eriksson, Medicinaregatan 3.
Titel: Study of the balance of T helper cell subsets in response to eosinophilopiesis in airway allergic inflammation.

Torsdagen den 13 januari kl.  11:00 möte i styrgruppen för Krefting Research Centre.

Tisdagen den 11 januari kl. 15:00 har Cecilia Lässer halvtids-
seminarium. Sal: Ingegerd Eriksson,  Academicum, Medicinaregatan 3.
Titel: Study of RNA-containing exosomes in human: detection, characterisation and capacity for cell-to-cell communication.

2010

Fredagen den 17 december kl. 10:00 har Maria Eldh halvtidsseminarium. Sal: Ingegerd Eriksson, Academicum,
Medicinaregatan 3.
Titel: Role of shuttle of exosomal RNA between cells in oxidative stress.

Torsdagen den 16 december kl. 10:00 har Linda Ekerljung halvtidsseminarium. Sal: Ingegerd Eriksson, Academicum,
Medicinaregatan 3.
Titel: Translationell astmastudie från klinisk epidemiologi till proteomik syftande till att identifiera kliniskt relevanta astmafenotyper.

Torsdagen den 16 december kl. 12:00 möte i styrgruppen för Krefting Research Centre

Tisdagen den 2 november kl. 17:00 möte i styrgruppen för Krefting Research Centre

Kontakta Eva-Marie Romell om ni har fler datum att införa i detta kalendarium.


För internationella möten se nedan.

EAACI-nytt

EAACI Food Allergy Training Course – Abstract submission closing soon

[2017-03-29]

This training course aims to provide a broad overview of current state-of-the-art practices in preventing and treating food allergy. The course will be hosted at the University of Manchester, United Kingdom, from 14 -16 September 2017. The abstract submission is open until 30 June 2017 at 24:00 CET.
There will be a limited number of 120 places.
Visit the website here

[charalampos.kostaras@eaaci.org (Charalampos Kostaras)]

This training course aims to provide a broad overview of current state-of-the-art practices in preventing and treating food allergy. The course will be hosted at the University of Manchester, United Kingdom, from 14 -16 September 2017. The abstract submission is open until 30 June 2017 at 24:00 CET.
There will be a limited number of 120 places.
Visit the website here

EAACI Master Class on Occupational Allergy – Registration is open

[2017-04-26]

The main goal is to review the importance and role of different known and potential biomarkers useful to define the pathophysiological and clinical profiles of patients affected by occupational lung disease, particularly occupational asthma. The course will be hosted at the Hospital La Paz in Madrid, Spain, from 29-30 September 2017.
There will be a limited number of 100 places.
Visit the website here

[charalampos.kostaras@eaaci.org (Charalampos Kostaras)]

The main goal is to review the importance and role of different known and potential biomarkers useful to define the pathophysiological and clinical profiles of patients affected by occupational lung disease, particularly occupational asthma. The course will be hosted at the Hospital La Paz in Madrid, Spain, from 29-30 September 2017.
There will be a limited number of 100 places.
Visit the website here

EAACI recruits new Editors-in-Chief for its journal – Allergy

[2017-06-01]

The European Academy of Allergy and Clinical Immunology (EAACI) is seeking to appoint two co-Editors-in-Chief to succeed Prof. Thomas Bieber and Prof. Hans-Uwe Simon, who will finishing their term as editors of the journal at the end of December 2017.

Allergy (ALL) one of the leading journals in the field of Allergy and Clinical immunology. With an Impact Factor of 6.335 Allergy ranks 2/25 (Allergy) and 21/151 (Immunology). The journal is co-owned by EAACI and John Wiley and Sons A/S and published by John Wiley and Sons, Ltd.

For more information, job description and application details, please click here.

[charalampos.kostaras@eaaci.org (Charalampos Kostaras)]

The European Academy of Allergy and Clinical Immunology (EAACI) is seeking to appoint two co-Editors-in-Chief to succeed Prof. Thomas Bieber and Prof. Hans-Uwe Simon, who will finishing their term as editors of the journal at the end of December 2017.

Allergy (ALL) one of the leading journals in the field of Allergy and Clinical immunology. With an Impact Factor of 6.335 Allergy ranks 2/25 (Allergy) and 21/151 (Immunology). The journal is co-owned by EAACI and John Wiley and Sons A/S and published by John Wiley and Sons, Ltd.

For more information, job description and application details, please click here.

Welcome to ISMA 2017

[2017-02-24]

The International Symposium on Molecular Allergology (isma) will take place in Luxembourg on the 9th-11th November 2017.
We are now accepting abstract submissions. For all information surrounding isma, we invite you to view the website.
Find out more and register here

[charalampos.kostaras@eaaci.org (Charalampos Kostaras)]

The International Symposium on Molecular Allergology (isma) will take place in Luxembourg on the 9th-11th November 2017.
We are now accepting abstract submissions. For all information surrounding isma, we invite you to view the website.
Find out more and register here

About Us

[2014-04-16]

534Welcome to the Insect Hypersensitivity Interest Group

From the EAACI Bylaws

In order to allow EAACI to influence and keep updated information on matters related to allergy and clinical immunology, it has been decided to create “Interest Groups”. An Interest Group represents an area of general interest within allergology that is not well covered by any one of the EAACI Sections.

Announcement:
You may be interested in participating in our EAACI multicenter study EADOAS, that is about to start. EADOAS means “The effect of antihypertensive drugs on severity of anaphylaxis and side –effects during venom immunotherapy”. A sufficiently powered study on the effect of antihypertensive drugs is urgently needed. This will be the first well planned study on this topic. We plan to enroll 1319 patients, which is a lot, and we therefore would be happy, if you can join the study group. Please feel free to inform other interested centers. If you would like to join, you should be able to: - Include at least 30 patients. Most of them should get VIT, and 25-30% should take beta blockers and/or ACE inhibitors during VIT
- To obtain approval of your local ethical review board
- To create an informed consent form in your language based on the protocol and according to your local policies (German is available)
- To perform standard diagnostic procedures to diagnose hymenoptera venom allergy and to perform VIT.
- To store at least 2ml serum per patient at -20°C for further analysis (shipment costs will be covered)
- To provide personal resources to enroll patients in the study and to complete paper and e-CRFs
For further information, send an email to the leader of this interesting project Dr. Gunter Sturm: gunter.sturm@medunigraz.at

Announcement:
The cross-cultural validation of the Vespid Quality of Life Questionnaire (VQLQ) is in progress.
Would you like to collaborate in this interesting project? Send an email to (j.n.g.oude.elberink@umcg.nl)
Thank you very much

[dario.antolin@gmail.com (Dario Antolin)]534Welcome to the Insect Hypersensitivity Interest Group

From the EAACI Bylaws

In order to allow EAACI to influence and keep updated information on matters related to allergy and clinical immunology, it has been decided to create “Interest Groups”. An Interest Group represents an area of general interest within allergology that is not well covered by any one of the EAACI Sections.

Announcement:
You may be interested in participating in our EAACI multicenter study EADOAS, that is about to start. EADOAS means “The effect of antihypertensive drugs on severity of anaphylaxis and side –effects during venom immunotherapy”. A sufficiently powered study on the effect of antihypertensive drugs is urgently needed. This will be the first well planned study on this topic. We plan to enroll 1319 patients, which is a lot, and we therefore would be happy, if you can join the study group. Please feel free to inform other interested centers. If you would like to join, you should be able to: - Include at least 30 patients. Most of them should get VIT, and 25-30% should take beta blockers and/or ACE inhibitors during VIT
- To obtain approval of your local ethical review board
- To create an informed consent form in your language based on the protocol and according to your local policies (German is available)
- To perform standard diagnostic procedures to diagnose hymenoptera venom allergy and to perform VIT.
- To store at least 2ml serum per patient at -20°C for further analysis (shipment costs will be covered)
- To provide personal resources to enroll patients in the study and to complete paper and e-CRFs
For further information, send an email to the leader of this interesting project Dr. Gunter Sturm: gunter.sturm@medunigraz.at

Announcement:
The cross-cultural validation of the Vespid Quality of Life Questionnaire (VQLQ) is in progress.
Would you like to collaborate in this interesting project? Send an email to (j.n.g.oude.elberink@umcg.nl)
Thank you very much

2016-2017 Insect Venom Hypersensitivity IG Position Papers and EAACI Task Force Consensus Statement

[2017-02-12]

Position Papers and EAACI Task Force Consensus Statement

Please find below the links to relevant articles produced by members of the Insect Venom Hypersensitivity Interest Group

Self-medication of anaphylactic reactions due to Hymenoptera stings. An EAACI Task Force Consensus Statement
Allergen Immunotherapy for insect venom allergy: a systematic review and meta-analysis
Allergen Immunotherapy: Protocol for a systematic review

[dario.antolin@gmail.com (Dario Antolin)]

Insect Venom Hypersensitivity IG 2015 Report

[2016-11-13]

Insect Venom Hypersensitivity IG 2015 Report

Contribution of IG board members to international multicenter studies and Task Forces of the other EAACI Interest Groups

Publications:

1. Siracusa A1Folletti IGerth van Wijk RJeebhay MFMoscato GQuirce SRaulf MRuëff FWalusiak-Skorupa JWhitaker PTarlo SM. Occupational anaphylaxis--an EAACI task force consensus statement.. 2015 Feb;70(2):141-52. doi: 10.1111/all.12541.

2. Pitsios C, Demoly P, Bilò MB, Gerth van Wijk R, Pfaar O, Sturm GJ, Rodriguez del Rio P, Tsoumani M, Gawlik R, Paraskevopoulos G, Ruëff F, Valovirta E, Papadopoulos NG, Calderón MA.Clinical contraindications to allergen immunotherapy: an EAACI position paper. Allergy. 2015 Aug;70(8):897-909.

3. Bonadonna P, Pagani M, Aberer W, Bilò MB, Brockow K, Oude Elberink H, Garvey L, Mosbech H, Romano A, Zanotti R, Torres MJ. Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paper. Allergy. 2015 Jul;70(7):755-63.

[dario.antolin@gmail.com (Dario Antolin)]

Minutes of the Insect Venom Hypersensitivity IG yearly Business Meeting, EAACI Congress Vienna 2016

[2016-07-09]

Minutes of the Insect Venom Hypersensitivity IG  yearly Business Meeting, EAACI Congress Vienna 2016: (if you press in the available talks you can see the pdf version)



Business Meeting took place on Monday 13th of June from 17.30 to 18.40, Congress Venue room Schubert 4-6

Chair: Gunter Sturm, Austria                                       gunter.sturm@medunigraz.at

Secretary: Ewa Cichocka-Jarosz, Poland                    mijarosz@cyf-kr.edu.pl

The other Board members (in the alphabetical order):



Dario Antolin Amerigo, Spain, additionally webmaster dario.antolin@gmail.com

Ervin Mingomataj, Albania                                           mingomataj@gmail.com

Hanneke Oude Elberink, The Netherlands                  j.n.g.oude.elberink@umcg.nl

Franziska Ruëff, Germany                                          Franziska.Rueff@med.uni-muenchen.de

Betul Ayse Sin, Turkey                                                betulasin@gmail.com

JMA Affiliate Elisa Boni, Italy                                       boni6055@gmail.com

Sixty five persons attended the BM.

Agenda was as follows:

1.    Introductory lecture: Patrizia Bonadonna (Italy) as an invited speaker, gave a lecture entitled “Insect venom allergy and mastocytosis”. After the lecture there was a vivid discussion

2.    Introduction Gunter Sturm, Austria

3.    Polistes allergy

a.       Situation in Italy – Elisa Boni, Italy

b.      Situation in Spain - Dario Antolin Amerigo, Spain

4.    Report on ongoing task forces:

a.       “Self-medication and other recommendations for patients with hypersensitivity reactions to stings” - Maria Beatrice Bilo, Italy.

                                                  i.      Task Force Consensus Statement was published in Allergy 2016 Jul;71(7):931-43.

b.      “Sting challenge” - Franziska Rueff, Germany. Next draft will be prepared soon.

c.       Diagnosis of Hymenoptera venom allergy - Gunter Sturm, Austria – main chapters are finished, final draft is planned to be finished until September, 2016, next the review phase lasting for 6 weeks is planned

d.      Update on the progress of EAACI Treatment guidelines” (chair Eva Maria Varga, Gunter Sturm) - Gunter Sturm, Austria. Time schedule is established as follows:

                             i.      Phase 1 was ended by the publication of protocol for systematic review in Clinical Translational Allergy 2016 Feb 16;6:6

                             ii.      Currently Phase 2: June 29-30: Meeting of all TF members in Venice, finalization  of systematic review,  publication of systematic review until October 2016.

                             iii.      planned Phase 3: Creating a 1st draft of guidelines by the chairs. November 10-11: Meeting of all TF members as well as stakeholders, external experts/reviewers to achieve the final consensus. After the meeting, a 2nd draft of the guidelines will be prepared.  

 

5.    Update on EADOAS-Study (The effect of antihypertensive drugs on severity of anaphylaxis and side – effects during venom immunotherapy) - Christoph Schrautzer, Austria, Gunter Sturm,

a.       551 patients (42%) of 1319 were enrolled

b.      Perfect proportion of patients with ACEI and BB: 29.8% (calc. 24%)

c.       Inclusion phase should be finished in 2017.

6.    Future projects - the scientific board of the Insect Venom Hypersensitivity IG welcomes suggestions for future scientific meetings. Everybody is invited to make proposals, even if he/she is not member of the steering committee.

[dario.antolin@gmail.com (Dario Antolin)]

Insect Venom Hypersensitivity IG 2016 Report

[2016-11-13]

Insect Venom Hypersensitivity IG 2016 REPORT

Publications:

1. Dhami S, Nurmatov U, Varga EM, Sturm G, Muraro A, Akdis CA, Antolín-Amérigo D, Bilò MB, Bokanovic D, Calderon MA, Cichocka-Jarosz E, Elberink JN, Gawlik R, Jakob T, Kosnik M, Lange J, Mingomataj E, Mitsias DI, Mosbech H, Pfaar O, Pitsios C, Pravettoni V, Roberts G, Ruëff F, Sin BA, Sheikh A. Allergen immunotherapy for insect venom allergy: protocol for a systematic review. Clin Transl Allergy. 2016 Feb 16;6:6.

2. Bilò MB, Cichocka-Jarosz E, Pumphrey R, Oude-Elberink JN, Lange J, Jakob T, Bonadonna P, Fernandez J, Kosnik M, Helbling A, Mosbech H, Gawlik R, Niedoszytko M, Patella V, Pravettoni V, Rodrigues-Alves R, Sturm GJ, Rueff F. Self-medication of anaphylactic reactions due to Hymenoptera stings-an EAACI Task Force Consensus Statement. Allergy 2016 Jul;71(7):931-43.

3. Dhami S, Zaman H, Varga E-M, Sturm G, Muraro A, Akdis CA, Antolín-Amérigo D, Bilò BM, Bokanovic D, Calderon MA, Cichocka-Jarosz E, Oude Elberink JNG, Gawlik R, Jakob T, Kosnik M, Lange J, Mingomataj E, Mitsias DI, Mosbech H, Ollert M, Pfaar O, Pitsios C, Pravettoni V, Roberts G, Ruëff F, Ayşe Sin B, Netuveli G, Sheikh A. Allergen immunotherapy for insect venom allergy: a systematic review and meta-analysis. Allergy 2016 - accepted for publication

4. Contribution of IG board members to international multicenter studies and Task Forces of the other EAACI Interest Groups:

◦ Grabenhenrich LB, Dölle S, Moneret-Vautrin A, Köhli A, Lange L, Spindler T, Ruëff F, Nemat K, Maris I, Roumpedaki E, Scherer K, Ott H, Reese T, Mustakov T, Lang R, Fernandez-Rivas M, Kowalski ML, Bilò MB, Hourihane JO, Papadopoulos NG, Beyer K, Muraro A, Worm M. Anaphylaxis in children and adolescents: The European Anaphylaxis Registry. J Allergy Clin Immunol. 2016 Apr;137(4):1128-37.e1.

◦ Matricardi PM, Kleine-Tebbe J, Hoffmann HJ, Valenta R, Hilger C, Hofmaier S, Aalberse RC, Agache I, Asero R, Ballmer-Weber B, Barber D, Beyer K, Biedermann T, Bilò MB,
Blank S, Bohle B, Bosshard PP, Breiteneder H, Brough HA, Caraballo L, Caubet JC, Crameri R, Davies JM, Douladiris N, Ebisawa M, EIgenmann PA, Fernandez-Rivas M, Ferreira F, Gadermaier G, Glatz M, Hamilton RG, Hawranek T, Hellings P, Hoffmann-Sommergruber K, Jakob T, Jappe U, Jutel M, Kamath SD, Knol EF, Korosec P, Kuehn A, Lack G, Lopata AL, Mäkelä M, Morisset M, Niederberger V, Nowak-Węgrzyn AH, Papadopoulos NG, Pastorello EA, Pauli G, Platts-Mills T, Posa D, Poulsen LK, Raulf M, Sastre J, Scala E, Schmid JM, Schmid-Grendelmeier P, van Hage M, van Ree R, Vieths S, Weber R, Wickman M, Muraro A, Ollert M. EAACI Molecular Allergology User's Guide. Pediatr Allergy Immunol. 2016 May;27 Suppl 23:1-250.

◦ Brockow K, Aberer W, Atanaskovic-Markovic M, Bavbek S, Bircher A, Bilo B, Blanca M, Bonadonna P, Burbach G, Calogiuri G, Caruso C, Celik G, Cernadas J, Chiriac A, Demoly P, Oude Elberink JN, Fernandez J, Gomes E, Garvey LH, Gooi J, Gotua M, Grosber M, Kauppi P, Kvedariene V, Laguna JJ, Makowska JS, Mosbech H, Nakonechna A, Papadopolous NG, Ring J, Romano A, Rockmann H, Sargur R, Sedlackova L, Sigurdardottir S, Schnyder B, Storaas T, Torres M, Zidarn M, Terreehorst I. Drug allergy
passport and other documentation for patients with drug hypersensitivity - An ENDA/EAACI Drug Allergy Interest Group Position Paper. Allergy. 2016 May 4.

◦ Dhami S, Nurmatov U, Roberts G, Pfaar O, Muraro A, Ansotegui IJ, Calderon M, Cingi C, Demoly P, Durham S, van Wijk RG, Halken S, Hamelmann E, Hellings P, Jacobsen L,
Knol E, Linnemann DL, Lin S, Maggina V, Oude-Elberink H, Pajno G, Panwankar R, Pastorello E, Pitsios C, Rotiroti G, Timmermans F, Tsilochristou O, Varga EM, Wilkinson
J, Williams A, Worm M, Zhang L, Sheikh A. Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review. Clin Transl Allergy. 2016 Mar
22;6:12.

◦ Mayorga C, Celik G, Rouzaire P, Whitaker P, Bonadonna P, Rodrigues-Cernadas J, Vultaggio A, Brockow K, Caubet JC, Makowska J, Nakonechna A, Romano A, Montañez
MI, Laguna JJ, Zanoni G, Gueant JL, Oude Elberink H, Fernandez J, Viel S, Demoly P, Torres MJ; In vitro tests for Drug Allergy Task Force of EAACI Drug Interest Group. In
vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy. 2016 Aug;71(8):1103-34.

◦ Hartmann K, Escribano L, Grattan C, Brockow K, Carter MC, Alvarez-Twose I, Matito A, Broesby-Olsen S, Siebenhaar F, Lange M, Niedoszytko M, Castells M, Oude Elberink JN, Bonadonna P, Zanotti R, Hornick JL, Torrelo A, Grabbe J, Rabenhorst A, Nedoszytko B, Butterfield JH, Gotlib J, Reiter A, Radia D, Hermine O, Sotlar K, George TI, Kristensen TK, Kluin-Nelemans HC, Yavuz S, Hägglund H, Sperr WR, Schwartz LB, Triggiani M, Maurer M, Nilsson G, Horny HP, Arock M, Orfao A, Metcalfe DD, Akin C, Valent P. Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology. Allergy Clin Immunol. 2016 Jan;137(1):35-45.

[dario.antolin@gmail.com (Dario Antolin)]

Insect Hypersensitivity Board 2011-2013

[2017-03-02]

Insect Hypersensitivity 2011-2013

Franziska Ruëff
 Ewa Cichocka-Jarosz
 Javier Fernandez
 Ervin Mingomataj
 Gunter Sturm

[dario.antolin@gmail.com (Dario Antolin)]

Kontaktinformation

Krefting Research Centre Göteborgs universitet

Box 424, 405 30 Göteborg

Sidansvarig: Eva-Marie Romell|Sidan uppdaterades: 2017-01-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?